What is Prima-Temp?
Prima-Temp operates at the intersection of reproductive health and artificial intelligence, providing a comprehensive ecosystem for continuous core temperature tracking. By integrating the Priya Personal Fertility System with the Kindara platform, the company has cultivated a robust data-driven environment that facilitates precise ovulation prediction and long-term health monitoring. Their technological architecture utilizes health-trained AI to synthesize complex physiological patterns, effectively transforming raw biometric data into actionable clinical insights. This approach not only empowers individual users but also enhances the efficacy of remote patient monitoring, fostering more transparent and informed interactions between patients and healthcare providers in an increasingly virtualized medical landscape.
How much funding has Prima-Temp raised?
Prima-Temp has raised a total of $10.1M across 4 funding rounds:
Private Equity
$1.8M
Debt
$1.2M
Private Equity
$1.6M
Private Equity
$5.4M
Private Equity (2014): $1.8M, investors not publicly disclosed
Debt (2015): $1.2M, investors not publicly disclosed
Private Equity (2016): $1.6M, investors not publicly disclosed
Private Equity (2017): $5.4M, investors not publicly disclosed
Key Investors in Prima-Temp
Undisclosed Institutional Investor
A private equity firm focused on scaling high-growth technology companies within the healthcare and life sciences sectors.
Undisclosed Debt Financing Partner
A specialized financial institution providing structured debt solutions to support operational liquidity and capital expenditure for emerging tech firms.
Undisclosed Strategic Backer
An investment entity with a mandate to support innovative digital health platforms that demonstrate significant potential for clinical integration.
What's next for Prima-Temp?
With the successful deployment of its latest capital, Prima-Temp is well-positioned to scale its enterprise-level health solutions. The strategic roadmap likely involves deepening the integration of its AI diagnostic tools into broader clinical workflows and expanding its wearable technology portfolio to address a wider spectrum of women's health indicators. As the company transitions into a more mature lifecycle stage, the focus will shift toward establishing strategic partnerships with healthcare systems and insurance providers, aiming to standardize its digital health interventions as a primary component of modern, proactive reproductive care. The firm's ability to maintain data integrity while scaling its user base will be the primary determinant of its long-term market dominance.
See full Prima-Temp company page
